Pfizer and Merck KGaA’s tweaks to the Javelin Lung 100 study of their PD-L1 antibody avelumab, which will delay its readout by almost two years, look like a painful but necessary adjustment to commercial realities in this competitive cancer indication. The changes will more than double the size of the study, in first-line non-small cell lung cancer, and push data out to mid-2019.
Category: Publishing
Teen makes the best bucket list ever for her dog with cancer 0:0
When Lauren Watt learned in 2015 that her best friend, Gizelle, had cancer and wouldn’t live much longer, she created a bucket list of all the things they wanted to do together before Gizelle passed away. “It was a silly thing,” said Watts, now 27, of her final plans for Gizelle, her 7-year-old mastiff.
How President Trump reshaped his stump speech for Congress
… Secondly, we should help Americans purchase their own coverage, through the use of tax credits and expanded Health Savings Accounts – but it must be the plan they want, not the plan forced on them by the Government. Thirdly, we should give our great …
Take back our water: How Trump’s appetite for privatization threatens your drinking water
The Trump administration is pushing infrastructure privatization. But private, for-profit corporations are not good bets for managing municipal drinking water systems in the public interest.
Bristol-Myers Squibb stock sinks 7.2% after it says it won’t pursue…
The company said the decision was made “based on a review of the data available at this time,” and said it would say no more “in order to protect the integrity of ongoing registrational studies.” Leerink analyst Seamus Fernandez said the development was a “clear setback for BMY,” especially given a fall approval by rival drugmaker Merck in first-line lung cancer.
Transition Tracker: Health insurance for everybody edition
President-elect Donald Trump now says he wants “insurance for everybody” when Obamacare is replaced, which caused nearly every pundit in Washington and beyond scrambling to figure out what exactly he means. Will everyone get health care? Or will everyone get access to health care? Does that mean it’ll be affordable to everyone? Can he get the Republican Congress unified behind that plan? Trump made waves over the weekend, telling The Washington Post that he wants “insurance for everybody,” and urging Congress to quickly put the replacement plan in place.
Transition Tracker: Health insurance for everybody edition
President-elect Donald Trump now says he wants “insurance for everybody” when Obamacare is replaced, which caused nearly every pundit in Washington and beyond scrambling to figure out what exactly he means. Will everyone get health care? Or will everyone get access to health care? Does that mean it’ll be affordable to everyone? Can he get the Republican Congress unified behind that plan? Trump made waves over the weekend, telling The Washington Post that he wants “insurance for everybody,” and urging Congress to quickly put the replacement plan in place.
Sanders gets ‘Four Pinocchios’ for Obamacare repeal tweet about 36K deaths
Vermont Sen. Bernie Sanders received a fact-check smackdown from the Washington Post on Saturday for his statement claiming 36,000 more Americans would die annually if the Affordable Care Act is repealed. ThinkProgress published a story arguing that nearly 30 million people would lose health insurance if Obamacare is repealed and one in every 830 of those people would die because of repeal, leading to just under 36,000 people who could die every year because they don’t have insurance.
North Coast Rep Heralds New Year with Critically Acclaimed Hit,…
North Coast Repertory Theatre continues its highly successful Season 35 with the San Diego premiere of Marjorie Prime, hailed as “an elegant, thoughtful, quietly unsettling drama” by The New York Times. Written by Jordan Harrison, the play enjoyed triumphant runs in Los Angeles and New York and was a finalist for the 2015 Pulitzer Prize for drama and won the 2016 Horton Foote Prize, which honors excellence in American theatre.